| Strengthening Our System: Meeting the Challenges of Balancing Access, Innovation, and Cost |
| Sponsored by Centocor, Inc. |
| Monday, November 10, 2008 - 12:00 p.m. - 1:30 p.m. |
|
With the beginning of a new Presidential Administration and a new Congressional session in 2009, access to healthcare and to new therapies and devices will be a priority. With the increasing pressures to control healthcare costs and improve access, all while continuing to encourage innovation for unmet medical needs, how do we balance these concerns? The Federal Food and Drug Administration and the Centers for Medicare and Medicaid Services will be central to solving these issues. Are they receiving the support necessary to accomplish their missions? What more needs to be done to ensure that we have agencies that are funded to meet the pressures of our healthcare needs?
Moderator:
Panelists:
-
The Honorable Allyson Schwartz, US House of Representatives, 13th Congressional District of Pennsylvania
-
The Honorable James Greenwood, president & CEO, Biotechnology Industry Organization
|
| Overview of the Industry: Past, Present, and Future |
| Sponsored by Ernst & Young |
| Monday, November 10, 2008 - 3:15 p.m. - 4:30 p.m. |
|
A discussion of the present and future state of the biotechnology industry in the Mid-Atlantic corridor will again be featured at this year's Symposium. Our speakers will also focus on some key trends that will provoke your thoughts and interest. This back-by-popular demand panel will cover trends from the past, what is currently keeping CEOs and CFOs up at night, and what these experts see in the future.
Moderator:
Panelists:
- Mike Erickson, Ph.D., associate partner, McKinsey & Company
- Doug Long, vice president of industry relations, IMS Health
|
|
